ZA875090B - Substituted hexahydro arylquinolizines - Google Patents

Substituted hexahydro arylquinolizines

Info

Publication number
ZA875090B
ZA875090B ZA875090A ZA875090A ZA875090B ZA 875090 B ZA875090 B ZA 875090B ZA 875090 A ZA875090 A ZA 875090A ZA 875090 A ZA875090 A ZA 875090A ZA 875090 B ZA875090 B ZA 875090B
Authority
ZA
South Africa
Prior art keywords
substituted hexahydro
arylquinolizines
hexahydro arylquinolizines
substituted
hexahydro
Prior art date
Application number
ZA875090A
Other languages
English (en)
Inventor
R. Huff Joel
P. Vacca Joseph
J. Baldwin John
Original Assignee
Merck & Co. Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co. Inc. filed Critical Merck & Co. Inc.
Publication of ZA875090B publication Critical patent/ZA875090B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D497/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D497/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D497/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains three hetero rings
    • C07D513/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ZA875090A 1986-07-14 1987-07-13 Substituted hexahydro arylquinolizines ZA875090B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/885,511 US4690928A (en) 1984-02-02 1986-07-14 Substituted hexahydro arylquinolizines as α2 blockers

Publications (1)

Publication Number Publication Date
ZA875090B true ZA875090B (en) 1988-01-08

Family

ID=25387064

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA875090A ZA875090B (en) 1986-07-14 1987-07-13 Substituted hexahydro arylquinolizines

Country Status (10)

Country Link
US (1) US4690928A (xx)
EP (1) EP0253572A1 (xx)
JP (1) JPS6323880A (xx)
KR (1) KR880001664A (xx)
AU (1) AU7524987A (xx)
DK (1) DK362987A (xx)
IL (1) IL83101A0 (xx)
NZ (1) NZ220955A (xx)
PT (1) PT85277A (xx)
ZA (1) ZA875090B (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU582663B2 (en) * 1985-08-10 1989-04-06 John Wyeth & Brother Limited Sulphonamides
US4835276A (en) * 1986-07-03 1989-05-30 Merck & Co., Inc. Preparation of n-formamidoyl[(s)-1-t-butoxy-3-methyl-2-amino)]1,2,3,4 tetrahydrobenzo [b]furo [2,3-c]pyridine and derivatives
US4886798A (en) * 1987-04-13 1989-12-12 Syntex (U.S.A.) Inc. Optical isomers of sulfonyldecahydro-8H-isoquino-(2,1-G)(1,6) naphthyridines and related compounds useful as α2 -blockers
US4956365A (en) * 1987-04-13 1990-09-11 Syntex (U.S.A.) Inc. Decahydro-8H-isoquino(2,1-g)(1,6)naphthyridine derivatives and related compounds
US4791108A (en) * 1987-04-13 1988-12-13 Syntex (U.S.A.) Inc. Sulfonyl-decahydro-8H-isoquino[2,1-G][1,6]-naphthyridines and related compounds useful as α2 -blockers
US4968692A (en) * 1989-01-06 1990-11-06 The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Attenuation of ethyl alcohol intoxication with alpha-2 adrenoceptor antagonists
CA1321751C (en) * 1989-02-21 1993-08-31 Eugene C. Crichlow Mechanism mediating ruminal stasis in ruminal lactic acidosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1435573A (en) * 1973-05-25 1976-05-12 Wyeth John & Brother Ltd Indoloquinolizines
US4181657A (en) * 1978-07-14 1980-01-01 Miles Laboratories, Inc. 2-Aminooctahydroindolo[2,3-a]quinolizines useful in treating cardiovascular disorders
GB2083029B (en) * 1980-08-28 1983-09-28 Wyeth John & Brother Ltd Benzoquinolizines
GB2106909B (en) * 1981-10-07 1984-09-19 Wyeth John & Brother Ltd Benzoquinolizines
GR850211B (xx) * 1984-02-02 1985-05-24 Merck & Co Inc

Also Published As

Publication number Publication date
JPS6323880A (ja) 1988-02-01
DK362987D0 (da) 1987-07-13
KR880001664A (ko) 1988-04-26
AU7524987A (en) 1988-01-21
IL83101A0 (en) 1987-12-31
EP0253572A1 (en) 1988-01-20
DK362987A (da) 1988-01-15
US4690928A (en) 1987-09-01
PT85277A (en) 1987-08-01
NZ220955A (en) 1990-04-26

Similar Documents

Publication Publication Date Title
IL83589A0 (en) Substituted benzoylphenyl-ureas
IL81209A0 (en) Substituted indoloquinoxalines
CS306786A1 (en) Rezonator laseru se zmenou frekvence zareni
ZA876302B (en) Substituted 1-aryl-3-tert.-butyl-pyrazoles
EP0240462A3 (en) Substituted aminooxypropanoate
ZA875090B (en) Substituted hexahydro arylquinolizines
ZA872432B (en) Substituted aminoxy-propionamides
ZA864096B (en) Substituted hexahydro arylquinolizines
ZA879548B (en) Substituted n-methylisoxazolidines
GB2187739B (en) Substituted pyrimidoindoles
ZA879546B (en) Substituted phenoxypyridines
IE861423L (en) Substituted hexahydro arylquinolizines
ZA877869B (en) Substituted amino-ketals
GB8614246D0 (en) Substituted pyrimidoindoles
IE871878L (en) Substituted hexahydro arylquinolizines
ZA876303B (en) Substituted benzoylphenylureas
IL95264A0 (en) Substituted dihydroisoxazoles
IL95264A (en) Substituted dihydroisoxazoles
IL82777A0 (en) Substituted benzylcyclopropyl-ethers
BG41315A1 (en) Herbicidic means
BG42286A1 (en) Cold- resisting means
BG43018A1 (en) Cytoquinine means
GB8604628D0 (en) Dazzle-reducing means
CS122086A1 (en) Zapojeni pro vyrobu stejnosmerneho stabilizovaneho napeti e stridaveho napeti pomoci menice napeti
CS69986A1 (en) Mechanizovana vyztuz pro dobyvani strmych sloji se zakladkou